☆ 4.6 Article

Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome

TOXICOLOGY AND APPLIED PHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome

Yong Chen et al.

Summary: This study used bioinformatics methods to investigate the association between PCOS and NAFLD and identified differentially expressed genes (DEGs). The results showed that DEGs were mainly enriched in immunity and inflammation-related pathways. By constructing PPI network and miRNA-gene network, key genes and miRNAs were predicted.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Add to Collection

Article Pharmacology & Pharmacy

Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS

Kehinde S. Olaniyi et al.

Summary: The study found that low-dose spironolactone (LDS) can improve endocrine-metabolic disturbances and inflammation-related comorbidities in experimentally-induced PCOS rats by modulating the circulating androgen-adiponectin status.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights

Antonio Mancini et al.

Summary: The pathophysiology of PCOS involves complex mechanisms such as obesity, insulin-resistance, oxidative stress, and low-grade inflammation, which may lead to obesity, insulin resistance, vitamin D deficiency, and immune dyscrasia. These factors can interact and exacerbate each other's effects, suggesting an inverse interaction from the traditional understanding.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Multidisciplinary Sciences

Non-alcoholic fatty liver disease in polycystic ovary syndrome women

Young Bin Won et al.

Summary: MetS diagnosis and hyperandrogenism at PCOS diagnosis were significantly associated with NAFLD occurrence, while 2-h insulin level in 75 g GTT and BMI>25 kg/m(2) were not. Elevated aspartate aminotransferase levels were significant for NAFLD risk, but liver enzyme elevations may not appear until late liver damage.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Urology & Nephrology

Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial

Supanat Burinkul et al.

Summary: This study aimed to compare the anti-androgenic effects of spironolactone and cyproterone acetate in transgender women. The results showed that cyproterone acetate had a significantly higher testosterone suppression efficacy than spironolactone.

JOURNAL OF SEXUAL MEDICINE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome

Mohammad Maysara Asfari et al.

BMJ OPEN GASTROENTEROLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome

Meijiao Wang et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone

Oluwaseun A. Adeyanju et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2019)

Add to Collection

Review Genetics & Heredity

Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review

Sairish Ashraf et al.

EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS (2019)

Add to Collection

Article Medicine, General & Internal

The glucose metabolism disorder and dyslipidemia among girls with different phenotype polycystic ovary syndrome

Marzieh Akbarzadeh et al.

JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China

Xiaowei Zhu et al.

LIPIDS IN HEALTH AND DISEASE (2018)

Add to Collection

Article Endocrinology & Metabolism

Cardiometabolic Risk in Hyperlipidemic Men and Women

Michael Leutner et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)

Add to Collection

Review Medicine, General & Internal

PCSK9 inhibition: the way forward in the treatment of dyslipidemia

Robert M. Stoekenbroek et al.

BMC MEDICINE (2015)

Add to Collection

Review Endocrinology & Metabolism

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

Mark O. Goodarzi et al.

NATURE REVIEWS ENDOCRINOLOGY (2011)

Add to Collection

Article Dermatology

Innovative Use of Spironolactone as an Antiandrogen in the Treatment of Female Pattern Hair Loss

Deepani Rathnayake et al.

DERMATOLOGIC CLINICS (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy

Micheline Monteiro de Resende et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)

Add to Collection

Article Medicine, Research & Experimental

Letrozole-induced polycystic ovaries in the rat: A new model for cystic ovarian disease

H Kafali et al.

ARCHIVES OF MEDICAL RESEARCH (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.